Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Asset Writedowns and Impairment (2023 - 2025)

Strata Critical Medical (SRTA) has disclosed Asset Writedowns and Impairment for 3 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • Quarterly Asset Writedowns and Impairment rose 129.05% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2025, changed N/A year-over-year, with the annual reading at $1.7 million for FY2025, N/A changed from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $1.7 million at Strata Critical Medical, up from -$30000.0 in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $5.7 million in Q2 2024, with the low at -$5.8 million in Q4 2024.
  • Average Asset Writedowns and Impairment over 3 years is $229500.0, with a median of $30500.0 recorded in 2024.
  • The sharpest move saw Asset Writedowns and Impairment crashed 71887.5% in 2024, then surged 129.05% in 2025.
  • Over 3 years, Asset Writedowns and Impairment stood at -$8000.0 in 2023, then plummeted by 71887.5% to -$5.8 million in 2024, then soared by 129.05% to $1.7 million in 2025.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $1.7 million, -$30000.0, and $30000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.